MiMedx Group, Inc. (NASDAQ:MDXG) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, and thank you for standing by. Welcome to the MiMedx Third Quarter 2024 Operating and Financial Results Conference Call.
Mimedx Group Inc. (MDXG)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Trigran Investments Douglas T. Granat | 7,690,369 | $45,450,081 | +72% | 4.97% |
| 2. | Cannell Capital J. Carlo Cannell | 3,599,310 | $21,271,922 | +9% | 4.37% |
| 3. | Renaissance Technologies Jim Simons | 1,524,230 | $9,008,199 | -3% | 0.01% |
| 4. | Royce & Associates Chuck Royce | 972,853 | $5,749,561 | +6% | 0.05% |
| 5. | Millennium Management Israel Englander | 576,916 | $3,409,574 | -36% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.16 | 5,000 | Officer | 102,200 | 2023-11-21 | Filing | |
| $6.50 | 42,025 | Officer | 100,000 | 2023-06-23 | Filing | |
| $6.33 | 57,975 | Officer | 57,975 | 2023-06-22 | Filing | |
| $6.99 | 20,000 | Officer, Director | 5,009,121 | 2016-05-20 | Filing | |
| $6.82 | 30,000 | Officer, Director | 4,989,121 | 2016-05-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.95 | 20,381 | Officer | 479,959 | 2024-03-13 | Filing | |
| $8.01 | 15,271 | Officer | 401,050 | 2024-02-20 | Filing | |
| $8.07 | 15,493 | Officer | 416,321 | 2024-02-16 | Filing | |
| $8.06 | 15,198 | Officer | 431,814 | 2024-02-15 | Filing | |
| $8.03 | 15,845 | Officer | 447,012 | 2024-02-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 28,195,249 | $247,272,334 | 61.19% | |
| 2. | 9,533,518 | $83,608,951 | 0% | |
| 3. | 6,567,254 | $57,594,817 | 0% | |
| 4. | 4,088,962 | $35,860,197 | 0% | |
| 5. | 3,430,400 | $30,084,608 | 1.56% |
News See All
MiMedx Group, Inc. (NASDAQ:MDXG) Q2 2024 Earnings Call Transcript
Operator: Greetings and welcome to the MiMedx Second Quarter 2024 Operating and Financial Results Conference Call. At this time, all participants are in a listen-only mode.
MiMedx Group, Inc. (NASDAQ:MDXG) Q1 2024 Earnings Call Transcript
MiMedx Group, Inc. beats earnings expectations. Reported EPS is $0.07, expectations were $0.04.
MiMedx Group, Inc. (NASDAQ:MDXG) Q4 2023 Earnings Call Transcript
MiMedx Group, Inc. misses on earnings expectations. Reported EPS is $0.04 EPS, expectations were $0.08. MiMedx Group, Inc.
MiMedx Group, Inc. (NASDAQ:MDXG) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, and thank you for standing by. Welcome to the MiMedx Third Quarter ‘23 Operating and Financial Results Conference Call.
MiMedx Group, Inc. (NASDAQ:MDXG) Q2 2023 Earnings Call Transcript
Operator: Good afternoon and thank you for standing by. Welcome to the MiMedx Second Quarter 2023 Operating and Financial Results Conference Call.
Hedge Fund and Insider Trading News: Nicolai Tangen, Steve Cohen, Citadel LLC, Elliott Management, Odey Asset Management, Two Sigma Advisors, Three Arrows Capital, Svelland Capital, Axon Enterprise Inc (AXON), Eagle Bulk Shipping Inc. (EGLE), and More
For a prolific art collector, Nicolai Tangen is remarkably relaxed about the prospect of masterpieces created by robots.
MiMedx Group, Inc. (NASDAQ:MDXG) Q1 2023 Earnings Call Transcript
Operator: Good afternoon and thank you for standing by. Welcome to the MiMedx First Quarter 2023 Operating and Financial Results Conference Call.
MiMedx Group, Inc. (NASDAQ:MDXG) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and thank you for standing by. Welcome to the MiMedx Fourth Quarter and Full Year 2022 Operating and Financial Results Conference Call.
Market Movers Today: MiMedx Group Inc (MDXG), Dean Foods Co (DF), NXT-ID Inc (NXTD), GTT Communications Inc (GTT), and More
What happened: Shares of MiMedx Group (NASDAQ:MDXG), a regenerative medicine company, dropped as much as 22% in early morning trading on Monday. As of 11:10 a.m. EST, the stock was down 13%.